Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1831-1834

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eitzman, D. T.
Right arrow Articles by Ginsburg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eitzman, D. T.
Right arrow Articles by Ginsburg, D.
Related Collections
Right arrow Lipids
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Coagulation and fibronolysis
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1831.)
© 2000 American Heart Association, Inc.


Thrombosis

Hyperlipidemia Promotes Thrombosis After Injury to Atherosclerotic Vessels in Apolipoprotein E–Deficient Mice

Daniel T. Eitzman; Randal J. Westrick; Zuojun Xu; Julia Tyson; David Ginsburg

From the Cardiovascular Research Center (D.T.E., Z.X.) and Division of Molecular Medicine and Human Genetics (D.G.), Department of Internal Medicine, and the Howard Hughes Medical Institute (R.J.W., J.T., D.G.), University of Michigan Medical Center, Ann Arbor.

Abstract—The increased risk of hyperlipidemia on the development of complications of atherosclerosis is well established. Cholesterol-lowering therapies lead to a decrease in the incidence of vascular thrombotic events that is out of proportion to the reduction in plaque size. This suggests that the occurrence of acute thrombosis overlying a disrupted plaque is influenced by changes in lipid levels. The influence of acute hyperlipidemia on the development of thrombosis overlying an atherosclerotic plaque in vivo has not been extensively studied. We used a murine model of vascular injury induced by a photochemical reaction to elicit thrombus formation overlying an atherosclerotic plaque. Fifteen apolipoprotein E–deficient mice were maintained on normal chow until the age of 30 weeks. Five days before the induction of thrombosis, 6 mice were started on a high fat diet, and 9 mice were continued on normal chow. Mice then underwent photochemical injury to the common carotid artery immediately proximal to the carotid bifurcation, where an atherosclerotic plaque is consistently present. Mice maintained on normal chow developed occlusive thrombi, determined by cessation of blood flow, 44±5 minutes (mean±SEM) after photochemical injury, whereas mice fed a high fat chow developed occlusive thrombosis at 27±3 minutes (P<0.02). Histological analysis confirmed the presence of acute thrombus formation overlying an atherosclerotic plaque. These studies demonstrate a useful model for assessing the determinants of thrombosis in the setting of atherosclerosis and show that acute elevations in plasma cholesterol facilitate thrombus formation at sites of atherosclerosis after vascular injury.


Key Words: carotid artery • transgenic mice • cholesterol • plaque • rose bengal




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Chen, M. Febbraio, W. Li, and R. L. Silverstein
A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein
Circ. Res., June 20, 2008; 102(12): 1512 - 1519.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Westrick, M. E. Winn, and D. T. Eitzman
Murine Models of Vascular Thrombosis
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2079 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. M. Wilson, R. B. McCaw, L. Leo, E. Arning, S. Lhotak, T. Bottiglieri, R. C. Austin, and S. R. Lentz
Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. R. Lentz
Another Lesson From the Factor V Leiden Mouse: Thrombin Generation Drives Arterial Disease
Circulation, April 12, 2005; 111(14): 1733 - 1734.
[Full Text] [PDF]


Home page
CirculationHome page
D. T. Eitzman, R. J. Westrick, Y. Shen, P. F. Bodary, S. Gu, S. L. Manning, S. L. Dobies, and D. Ginsburg
Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice
Circulation, April 12, 2005; 111(14): 1822 - 1825.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Schafer, K. Muller, A. Hecke, E. Mounier, J. Goebel, D. J. Loskutoff, and S. Konstantinides
Enhanced Thrombosis in Atherosclerosis-Prone Mice Is Associated With Increased Arterial Expression of Plasminogen Activator Inhibitor-1
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2097 - 2103.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Day, D. Duquaine, L. V. Mundada, R. G. Menon, B. V. Khan, S. Rajagopalan, and W. P. Fay
Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis
Circulation, May 27, 2003; 107(20): 2601 - 2606.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. D. Rekhter
How to evaluate plaque vulnerability in animal models of atherosclerosis?
Cardiovasc Res, April 1, 2002; 54(1): 36 - 41.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Westrick, P. F. Bodary, Z. Xu, Y.-C. Shen, G. J. Broze, and D. T. Eitzman
Deficiency of Tissue Factor Pathway Inhibitor Promotes Atherosclerosis and Thrombosis in Mice
Circulation, June 26, 2001; 103(25): 3044 - 3046.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Zhu, P. M. Farrehi, and W. P. Fay
Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice
Circulation, June 26, 2001; 103(25): 3105 - 3110.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. T. Eitzman, R. J. Westrick, Z. Xu, J. Tyson, and D. Ginsburg
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
Blood, December 15, 2000; 96(13): 4212 - 4215.
[Abstract] [Full Text] [PDF]